However, BG7 tumour cells were already more sensitive to low doses of BTZ (7.5 nM) at 24 h than killing by NK cells and thus, were not further sensitized by combination with allogeneic or autologous NK cells (Supplementary Table S2, Figure 2A–D). This evidence concerns the gene CASC3 and neoplasm.